Abstract 14425: Cyclin Y Protects Against Thoracic Aortic Dissection by Preserving Mitochondrial Fatty Acid Homeostasis in Vascular Smooth Muscle Cells
Abstract
Background: Thoracic aortic dissection (TAD) is a life-threatening vascular disease marked by medial degeneration, vascular smooth muscle cell (VSMC) loss, and extracellular matrix disruption, yet its underlying mechanisms remain poorly understood. Cyclin Y (CCNY), a cyclin family member involved in cellular homeostasis, is significantly upregulated in ascending aortic tissues from patients with acute Stanford type A aortic dissection. However, its role in TAD pathogenesis remains unclear. Here, we investigated the pathological role of CCNY in VSMCs during TAD development. MethodS: Global CCNY knockout mice (CCNY -/- ) and SMC-specific CCNY knockout mice (CCNY ΔSMC ) were treated with β-aminopropionitrile (BAPN) to induce TAD. Aortic phenotypes were assessed by incidence and survival analyses, along with echocardiographic evaluation of aortic dilation. Immunofluorescence staining and flow cytometry of aortic tissues and primary VSMCs were used to assess apoptosis and reactive oxygen species (ROS) production. Primary VSMCs were subjected to Ccny knockdown in vitro to assess intracellular ATP production, fatty acid β-oxidation, and mitochondrial ROS generation. ResultS: CCNY was upregulated in both human and mouse TAD tissues. Both global and SMC-specific CCNY deletion significantly increased TAD incidence, mortality, and aortic diameter, accompanied by exacerbated elastic lamella fragmentation. Single-cell RNA sequencing identified an apoptosis-associated VSMC cluster that expanded after CCNY deletion and displayed prominent fatty acid metabolic remodeling, including fatty acid transport, fatty acyl-CoA biosynthesis, and mitochondrial fatty acid β-oxidation. Consistently, TUNEL staining and flow cytometry confirmed increased VSMC apoptosis after CCNY loss in aortic tissues and primary VSMCs. Transmission electron microscopy further revealed reduced mitochondrial area and fragmented mitochondrial morphology in aortic VSMCs from CCNY ΔSMC mice compared with controls. Mechanistically, Ccny knockdown in primary VSMCs significantly reduced intracellular ATP production and fatty acid β-oxidation while markedly increasing mitochondrial ROS generation, indicating impaired mitochondrial fatty acid metabolic homeostasis. Conclusion: These results identify CCNY as a previously unrecognized protective regulator of aortic wall homeostasis. CCNY loss exacerbates TAD by impairing mitochondrial fatty acid metabolism, increasing oxidative stress, and promoting VSMC apoptosis. Thus, CCNY may represent a potential therapeutic target for thoracic aortic dissection.